您的购物车当前为空
别名 阿替布利单抗
Atibuclimab 是一种靶向 CD14 的嵌合单克隆抗体,由小鼠可变区和人类 IgG4 Fc 区构成。Atibuclimab 可用于治疗肌萎缩侧索硬化症。Atibuclimab 可减少 LPS 诱导的病症,并对 LPS 诱导的促炎细胞因子释放有抑制作用,可延迟抗炎细胞因子可溶性 TNF 受体 I 型的释放,

为众多的药物研发团队赋能,
让新药发现更简单!
Atibuclimab 是一种靶向 CD14 的嵌合单克隆抗体,由小鼠可变区和人类 IgG4 Fc 区构成。Atibuclimab 可用于治疗肌萎缩侧索硬化症。Atibuclimab 可减少 LPS 诱导的病症,并对 LPS 诱导的促炎细胞因子释放有抑制作用,可延迟抗炎细胞因子可溶性 TNF 受体 I 型的释放,
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,650 | In Stock | |
| 5 mg | ¥ 4,630 | In Stock | |
| 10 mg | ¥ 6,490 | In Stock | |
| 25 mg | ¥ 9,630 | In Stock | |
| 50 mg | ¥ 12,900 | In Stock | |
| 100 mg | ¥ 17,500 | In Stock |
Atibuclimab 相关产品
| 产品描述 | Atibuclimab is a chimeric monoclonal antibody targeting CD14, consisting of a mouse variable region and a human IgG4 Fc region. Atibuclimab can be used to treat amyotrophic lateral sclerosis. Atibuclimab reduces LPS-induced disease and inhibits LPS-induced pro-inflammatory cytokine release, delaying the release of anti-inflammatory cytokine soluble TNF receptor type I. |
| 别名 | 阿替布利单抗 |
| 分子量 | 145.28 kDa |
| CAS No. | 2417175-94-9 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容